| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in financing activities | -2,266 | -1,749 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 3 | 183 |
| Net change in cash, cash equivalents and restricted cash | -32,294 | -21,333 |
| Cash and cash equivalents at beginning of period | 102,785 | - |
| Cash and cash equivalents at end of period | 70,491 | - |
Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (VNDA)